Treatment of early-stage mycosis fungoides with oral bexarotene and phototherapy. A systematic review and meta-analysis.

Published: 3 June 2021| Version 1 | DOI: 10.17632/nnp3d5skd5.1
Erica Ginsburg


We performed a systematic review of the literature following the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines to identify patients with early-stage MF that have been treated with bexarotene and phototherapy (Supplemement 1). A comprehensive literature search was conducted utilizing Embase, Pubmed, Web of Science, and the Cochrane Library since inception. References from articles were also used to identify other studies that fit our criteria (Supplement 2). Risk-of-bias assessments were completed by independent reviewers (Supplement 3). The Cochrane Risk of Bias Assessment Tool was used to assess randomized control trials (RCTs).



University of South Florida


Cutaneous T-Cell Lymphoma, Light Therapy, Mycosis Fungoides, PUVA